David Kerr
David Kerr has been given a 5 year leave of absence from the University of Oxford to become the Chief Scientist for SIDRA, an academic Health Science Centre (www.sidra.org) endowed with $ 8 billion, and Director of Qatar’s national Biomedical Research Institute. From there, he plans to build a collaborative biomedical research network through the Middle East and contribute to improving Global Health. He has been appointed to the Supreme Council of Health, effectively Qatar’s Health cabinet, practices medicine in ‘Al Amal Cancer Hospital’ and contributes to Oxford as Professor of Cancer Medicine where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital. He is internationally renowned for his contributions in the treatment of and research into colorectal cancer. He is currently developing new approaches to cancer treatment which involve novel biomarkers and inhibitors of key biochemical pathways. He was awarded several international prizes and the first NHS Nye-Bevan award for innovation. He has published more than 350 articles in peer-reviewed journals (including New England Journal of Medicine, Lancet, Nature Genetics) and has contributed many books on cancer.